. 2019 Feb 14;10:110. doi: 10.3389/fphys.2019.00110

Table 3.

Relationships of O-GlcNAc/p-T212 with other clinical characteristics and different cognitive domains performances in T2DM patients.

	O-GlcNAc/p-T212
	r	p-value
Age (years)	0.077	0.604^a
Education levels (years)	-0.019	0.897^a
BMI (kg/m²)	0.239	0.102^a
Diabetes duration (years)	-0.065	0.659^a
HbA1c (%)	-0.346	0.016^a
FBG (mmol/L)	-0.329	0.023^a
FCP (ng/mL)	0.127	0.389^a
HOMA-IR (FCP)	-0.050	0.734^a
TG (mmol/L)	0.112	0.450^a
TC (mmol/L)	-0.143	0.334^a
HDL (mmol/L)	-0.245	0.094^a
LDL (mmol/L)	-0.194	0.187^a
SCr (μmol/L)	0.265	0.069^a
BUN (mmol/L)	-0.062	0.674^a
UA (μmol/L)	0.185	0.207^a
MoCA	0.397	0.006^b
DST	0.038	0.803^b
VFT	0.197	0.189^b
CDT	0.104	0.491^b
TMT-A	0.053	0.725^b
TMT-B	0.053	0.729^b
AVLT-immediate recall	0.215	0.152^b
AVLT-delayed recall	0.377	0.010^b

^aSpearman correlation.

^bPartial correlation after adjustment for HbA1c and FBG.

MCI, mild cognitive impairment; BMI, body mass index; HbA1c, glycosylated hemoglobin; FBG, fasting blood glucose; FCP, fasting C-peptide; HOMA-IR(FCP): replacing fasting insulin with FCP in the homeostasis model assessment of insulin resistance formula; TG, triglyceride; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SCr, serum creatinine; BUN, blood urea nitrogen; UA, uric acid; MoCA, Montreal Cognitive Assessment; DST, Digit Span Test; VFT, Verbal Fluency Test; CDT, Clock Drawing Test; TMT, Trail Making Test; AVLT, Auditory Verbal Learning Test.